Ana Alarcón Tomás
-
- CAR-T cell therapy research 15
-
- Hematopoietic Stem Cell Transplantation 2
- Acute Myeloid Leukemia Research 1
-
- Biosimilars and Bioanalytical Methods 4
-
- Virus-based gene therapy research 3
-
- Biomedical Ethics and Regulation 2
-
- Integrated Circuits and Semiconductor Failure Analysis 2
-
- Influenza Virus Research Studies 1
- Co-authors
- Miguel‐Angel PeralesMiriam Sánchez‐EscamillaSean M. DevlinLucrecia YáñezMichael ScordoCraig S. SauterKarthik NathRichard J. Lin
- Cited by
- OncologyHematologyImmunology
- Partner nations
- United StatesSpainThailand
In The Last Decade
Ana Alarcón Tomás
18 papers receiving 229 citations
Peers
Comparison fields: 5 of 42
- Oncology 177
- Hematology 33
- Immunology 42
- Genetics 38
- Pathology and Forensic Medicine 22
Countries citing papers authored by Ana Alarcón Tomás
This map shows the geographic impact of Ana Alarcón Tomás's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Alarcón Tomás with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Alarcón Tomás more than expected).
Fields of papers citing papers by Ana Alarcón Tomás
This network shows the impact of papers produced by Ana Alarcón Tomás. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Alarcón Tomás. The network helps show where Ana Alarcón Tomás may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ana Alarcón Tomás, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 11 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 99 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 14 | |
| 10 | 2023 | 2 | |
| 11 | 2023 | 1 | |
| 12 | 2022 | 14 | |
| 13 | 2021 | 3 | |
| 14 | 2021 | 1 | |
| 15 | 2020 | 29 | |
| 16 | 2020 | 2 | |
| 17 | 2018 | 2 | |
| 18 | 2018 | 20 | |
| 19 | 1991 | 8 | |
| 20 | 1989 | 2 |
About Ana Alarcón Tomás
Ana Alarcón Tomás is a scholar working on Oncology, Hematology and Immunology, having authored 22 papers that have together received 233 indexed citations. Recurring topics across this work include CAR-T cell therapy research (15 papers), Biosimilars and Bioanalytical Methods (4 papers), Virus-based gene therapy research (3 papers), Biomedical Ethics and Regulation (2 papers), Integrated Circuits and Semiconductor Failure Analysis (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), Acute Myeloid Leukemia Research (1 paper) and Influenza Virus Research Studies (1 paper). The work is most often cited by research in Oncology (177 citations), Hematology (33 citations) and Immunology (42 citations). Ana Alarcón Tomás has collaborated with scholars based in United States, Spain and Thailand. Frequent co-authors include Miguel‐Angel Perales, Miriam Sánchez‐Escamilla, Sean M. Devlin, Lucrecia Yáñez, Michael Scordo, Craig S. Sauter, Karthik Nath, Richard J. Lin, Parastoo B. Dahi and Gunjan L. Shah. Their work appears in journals such as Nature Medicine, Blood and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.